Manifestaciones clínicas de la toxicidad cutánea por telaprevir

Nicolas Dupin, Vincent Mallet, Agnès Carlotti, Anaïs Vallet-Pichard, Stanislas Pol, Severe skin rash in case of readministration of telaprevir in a patient who previously experienced a non severe rash. Hepatology. ,vol. 55, pp. 2042- 2043 ,(2012) , 10.1002/HEP.25574

Nicole Forestier, Stefan Zeuzem, Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders. Liver International. ,vol. 32, pp. 44- 50 ,(2012) , 10.1111/J.1478-3231.2011.02720.X

Gonzalo Crespo, Sabela Lens, Uso de boceprevir y telaprevir en pacientes con VHC (aspectos prácticos) Gastroenterología y Hepatología. ,vol. 35, pp. 337- 343 ,(2012) , 10.1016/J.GASTROHEP.2011.12.005

Bruce R. Bacon, Omer Khalid, Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders. Liver International. ,vol. 32, pp. 51- 53 ,(2012) , 10.1111/J.1478-3231.2011.02700.X

Patrice Cacoub, Marc Bourlière, Jann Lübbe, Nicolas Dupin, Peter Buggisch, Geoffrey Dusheiko, Christophe Hézode, Odile Picard, Ramon Pujol, Siegfried Segaert, Bing Thio, Jean-Claude Roujeau, Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. Journal of Hepatology. ,vol. 56, pp. 455- 463 ,(2012) , 10.1016/J.JHEP.2011.08.006

Jean-Claude Roujeau, Maja Mockenhaupt, Steven R. Tahan, Joshua Henshaw, Emily C. Martin, Matt Harding, Ben van Baelen, Leif Bengtsson, Priya Singhal, Robert S. Kauffman, Robert S. Stern, Telaprevir-Related Dermatitis JAMA Dermatology. ,vol. 149, pp. 152- 158 ,(2013) , 10.1001/JAMADERMATOL.2013.938

Maria Buti, Maria Homs, Nuevos agentes para el tratamiento de la hepatitis C Enfermedades Infecciosas Y Microbiologia Clinica. ,vol. 30, pp. 147- 150 ,(2012) , 10.1016/J.EIMC.2011.09.012

FRED WISE, MULTIPLE SUPERFICIAL BENIGN EPITHELIOMA OF THE SKIN Archives of Dermatology and Syphilology. ,vol. 19, pp. 1- 21 ,(1929) , 10.1001/ARCHDERM.1929.02380190004001

John G. McHutchison, Michael P. Manns, Andrew J. Muir, Norah A. Terrault, Ira M. Jacobson, Nezam H. Afdhal, E. Jenny Heathcote, Stefan Zeuzem, Hendrik W. Reesink, Jyotsna Garg, Mohammad Bsharat, Shelley George, Robert S. Kauffman, Nathalie Adda, Adrian M. Di Bisceglie M.D., Telaprevir for previously treated chronic HCV infection. The New England Journal of Medicine. ,vol. 362, pp. 1292- 1303 ,(2010) , 10.1056/NEJMOA0908014

Elisabeth Boerr, María Anders, José Mella, Emilio Quiñonez, Nicolás Goldaracena, Federico Orozco, Lucas Mccormack, Ricardo Mastai, Análisis del coste del trasplante hepático en un hospital de la comunidad: su relación con el Model for End-stage Liver Disease, un índice pronóstico que prioriza al paciente más grave Gastroenterología y Hepatología. ,vol. 36, pp. 1- 6 ,(2013) , 10.1016/J.GASTROHEP.2012.08.003